Eterna Therapeutics
ERNA
#10321
Rank
NZ$17.93 M
Marketcap
NZ$2.28
Share price
0.76%
Change (1 day)
-72.00%
Change (1 year)

Revenue for Eterna Therapeutics (ERNA)

Revenue in 2025 (TTM): NZ$0 Million

According to Eterna Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0 Million. In 2024 the company made a revenue of NZ$1.03 Million an increase over the revenue in the year 2023 that were of NZ$0.1 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eterna Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0 M-99.83%
2024 NZ$1.03 M859.73%
2023 NZ$0.1 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Baxter
BAX
NZ$19.08 B 1,102,299,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ$0.31 B 18,340,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.26 B 4,752,507,999.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
NZ$2.10 B 121,673,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
NZ$29.6 M 1,710,185.10%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
NZ$29.03 B 1,677,599,900.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel